Evidence map›Paper›PMID 41896529›Full record

ArticleNature communications2026

Structural dynamics of the midnolin-proteasome during ubiquitin-independent substrate turnover.

Chuanda Zhu, Lu Qin, Zonglin Dai, Peng Zuo, Ao Yang, Lijun Zhong, Zhiqiang Lin, Ling Liang

Erratum issuedAbstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Chuanda Zhu *Department of Biophysics, State Key Laboratory of Natural and Biomimetic Drugs, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.ORCID http://orcid.org/0000-0002-3774-747X
Lu Qin *Department of Biophysics, State Key Laboratory of Natural and Biomimetic Drugs, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
Zonglin DaiDepartment of Biophysics, State Key Laboratory of Natural and Biomimetic Drugs, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.ORCID http://orcid.org/0000-0002-4005-1297
Peng ZuoInstitute of Systems Biomedicine, Beijing Key Laboratory of Tumor Systems Biology, School of Basic Medical Sciences, Peking University, Beijing, China.ORCID http://orcid.org/0000-0002-5631-9534
Ao YangDepartment of Biophysics, State Key Laboratory of Natural and Biomimetic Drugs, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
Lijun ZhongCenter of Medical and Health Analysis, Peking University Health Science Center, Beijing, China.
Zhiqiang LinInstitute of Systems Biomedicine, Beijing Key Laboratory of Tumor Systems Biology, School of Basic Medical Sciences, Peking University, Beijing, China. zhiqiang_lin@bjmu.edu.cn.ORCID http://orcid.org/0000-0003-1834-2060
Ling LiangDepartment of Biophysics, State Key Laboratory of Natural and Biomimetic Drugs, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China. liangling@bjmu.edu.cn.ORCID http://orcid.org/0000-0002-3115-2563

Funding

National Natural Science Foundation of China (National Science Foundation of China) 22378004National Natural Science Foundation of China (National Science Foundation of China) 22595464National Natural Science Foundation of China (National Science Foundation of China) 32171224National Natural Science Foundation of China (National Science Foundation of China) 32571452
6 · The paper itself

Abstract

The 26S proteasome typically degrades proteins marked by ubiquitin chains. However, a distinct, ubiquitin-independent degradation pathway for nuclear proteins exists, mediated by the adaptor protein midnolin, yet its molecular mechanism remains poorly understood. Here, we present nine cryo-electron microscopy structures of the human 26S proteasome in complex with midnolin, which collectively delineate a near-complete catalytic cycle. Our structures reveal that midnolin binds to the proteasome via the RPN1 subunit by its C-terminal helix. Unexpectedly, its ubiquitin-like domain interacts with the RPN11 deubiquitinase in a non-catalytic role. This interaction positions the adjacent Catch domain, which is responsible for substrate binding, directly above the proteasomal entrance, potentially facilitating substrate entry into the proteasome. Furthermore, we observe four consecutive spiral staircase conformations of the AAA+ ATPase hexamer during substrate translocation. These findings provide insights into the mechanisms underlying ubiquitin-independent nuclear protein degradation and may help develop strategies for targeting nuclear proteins via direct proteasomal degradation.

Indexed as

Intracellular Signaling Peptides and ProteinsProteasome Endopeptidase ComplexCryoelectron MicroscopyHumansModels, MolecularProtein BindingProtein ConformationProteolysisSubstrate SpecificityUbiquitinADRM1 protein, humanATP dependent 26S proteaseIntracellular Signaling Peptides and ProteinsProteasome Endopeptidase ComplexUbiquitin

Identifiers

PMID41896529
PMCPMC13031973

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.